Aktis Oncology, Inc.
Pharmaceutical Preparations · Boston, MA, United States
- PrincipalsAkos CzibereChief Medical OfficerKyle D. KuvalankaChief Financial OfficerMatthew RodenPresident and CEOand 9 more
- CompanyAktis Oncology, Inc.Boston, MA, United States
- Phone line+1 (978) 237-4380General business
Aktis Oncology, Inc. is an SEC-registered Nasdaq-listed company (ticker AKTS) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 12
Chief executive
Matthew RodenPresident and CEO
Chair & board
Helen Susan KimDirector (Board)
Ken HerrmannDirector (Board)
Lloyd Mitchell SegalDirector (Board)
Mary ThistleDirector (Board)
Finance
Kyle D. KuvalankaChief Financial Officer
Operations
Shulamit Ron-BiggerChief Operating Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Akos Czibere — Chief Medical Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Kyle D. Kuvalanka — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Matthew Roden — President and CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Paul L Feldman — Chief Scientific Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Kiniksa Pharmaceuticals International, plcPharmaceutical Preparations · London1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityAmarin Corp PLC\UKPharmaceutical Preparations · Dublin 21 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityKazia Therapeutics LtdPharmaceutical Preparations · Sydney Nsw1 shared capabilityIncannex Healthcare Inc.Pharmaceutical Preparations · Norwest Nsw1 shared capability